Literature DB >> 18202920

Nitrated alpha-synuclein and microglial neuroregulatory activities.

Ashley D Reynolds1, Irena Kadiu, Sanjay K Garg, Jason G Glanzer, Tara Nordgren, Pawel Ciborowski, Ruma Banerjee, Howard E Gendelman.   

Abstract

Microglial neuroinflammatory responses affect the onset and progression of Parkinson's disease (PD). We posit that such neuroinflammatory responses are, in part, mediated by microglial interactions with nitrated and aggregated alpha-synuclein (alpha-syn) released from Lewy bodies as a consequence of dopaminergic neuronal degeneration. As disease progresses, secretions from alpha-syn-activated microglia can engage neighboring glial cells in a cycle of autocrine and paracrine amplification of neurotoxic immune products. Such pathogenic processes affect the balance between a microglial neurotrophic and neurotoxic signature. We now report that microglia secrete both neurotoxic and neuroprotective factors after exposure to nitrated alpha-syn (N-alpha-syn). Proteomic (surface enhanced laser desorption-time of flight, 1D sodium dodecyl sulfate electrophoresis, and liquid chromatography-tandem mass spectrometry) and limited metabolomic profiling demonstrated that N-alpha-syn-activated microglia secrete inflammatory, regulatory, redox-active, enzymatic, and cytoskeletal proteins. Increased extracellular glutamate and cysteine and diminished intracellular glutathione and secreted exosomal proteins were also demonstrated. Increased redox-active proteins suggest regulatory microglial responses to N-alpha-syn. These were linked to discontinuous cystatin expression, cathepsin activity, and nuclear factor-kappa B activation. Inhibition of cathepsin B attenuated, in part, N-alpha-syn microglial neurotoxicity. These data support multifaceted microglia functions in PD-associated neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202920      PMCID: PMC2430927          DOI: 10.1007/s11481-008-9100-z

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  79 in total

1.  Protective role of heat shock and heat shock protein 70 in lactacystin-induced cell death both in the rat substantia nigra and PC12 cells.

Authors:  Tae-Beom Ahn; Beom S Jeon
Journal:  Brain Res       Date:  2006-04-13       Impact factor: 3.252

2.  Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism.

Authors:  Ilaria Potolicchio; Gregory J Carven; Xiaonan Xu; Christopher Stipp; Richiard J Riese; Lawrence J Stern; Laura Santambrogio
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

3.  Exosomes are released by cultured cortical neurones.

Authors:  J Fauré; G Lachenal; M Court; J Hirrlinger; C Chatellard-Causse; B Blot; J Grange; G Schoehn; Y Goldberg; V Boyer; F Kirchhoff; G Raposo; J Garin; R Sadoul
Journal:  Mol Cell Neurosci       Date:  2006-01-30       Impact factor: 4.314

4.  Peroxiredoxin V is essential for protection against apoptosis in human lung carcinoma cells.

Authors:  Andrey Kropotov; Vladimir Gogvadze; Oleg Shupliakov; Nikolay Tomilin; Vladimir B Serikov; Nikolai V Tomilin; Boris Zhivotovsky
Journal:  Exp Cell Res       Date:  2006-05-17       Impact factor: 3.905

5.  Extracellular TNFR1 release requires the calcium-dependent formation of a nucleobindin 2-ARTS-1 complex.

Authors:  Aminul Islam; Barbara Adamik; Feras I Hawari; Ge Ma; Farshid N Rouhani; Jing Zhang; Stewart J Levine
Journal:  J Biol Chem       Date:  2006-01-05       Impact factor: 5.157

6.  LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia.

Authors:  Hongwei Qin; Cynthia A Wilson; Sun Jung Lee; Xueyan Zhao; Etty N Benveniste
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

7.  Biliverdin reductase, a major physiologic cytoprotectant, suppresses experimental autoimmune encephalomyelitis.

Authors:  Yingru Liu; Jie Liu; Wolfram Tetzlaff; Donald W Paty; Max S Cynader
Journal:  Free Radic Biol Med       Date:  2005-10-17       Impact factor: 7.376

8.  In vivo complementation of complex I by the yeast Ndi1 enzyme. Possible application for treatment of Parkinson disease.

Authors:  Byoung Boo Seo; Eiko Nakamaru-Ogiso; Terence R Flotte; Akemi Matsuno-Yagi; Takao Yagi
Journal:  J Biol Chem       Date:  2006-03-16       Impact factor: 5.157

9.  Calcium-binding properties of osteopontin derived from non-osteogenic sources.

Authors:  K Singh; D Deonarine; V Shanmugam; D R Senger; A B Mukherjee; P L Chang; C W Prince; B B Mukherjee
Journal:  J Biochem       Date:  1993-11       Impact factor: 3.387

10.  Cell-specific expression of the epm1 (cystatin B) gene in developing rat cerebellum.

Authors:  Massimo Riccio; Spartaco Santi; Maja Dembic; Rossella Di Giaimo; Elena Cipollini; Elvira Costantino-Ceccarini; Davide Ambrosetti; Nadir M Maraldi; Marialuisa Melli
Journal:  Neurobiol Dis       Date:  2005-10       Impact factor: 5.996

View more
  62 in total

1.  Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.

Authors:  Nadia Stefanova; Biljana Georgievska; Håkan Eriksson; Werner Poewe; Gregor K Wenning
Journal:  Neurotox Res       Date:  2011-12-08       Impact factor: 3.911

Review 2.  Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases.

Authors:  Lisa M Kosloski; Duy M Ha; Jessica A L Hutter; David K Stone; Michael R Pichler; Ashley D Reynolds; Howard E Gendelman; R Lee Mosley
Journal:  J Neurochem       Date:  2010-05-26       Impact factor: 5.372

3.  Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease.

Authors:  Natasa Kustrimovic; Emanuela Rasini; Massimiliano Legnaro; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-29       Impact factor: 4.147

Review 4.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

5.  microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease.

Authors:  Aaron D Thome; Ashley S Harms; Laura A Volpicelli-Daley; David G Standaert
Journal:  J Neurosci       Date:  2016-02-24       Impact factor: 6.167

Review 6.  Inflammation in the early stages of neurodegenerative pathology.

Authors:  Preeti J Khandelwal; Alexander M Herman; Charbel E-H Moussa
Journal:  J Neuroimmunol       Date:  2011-08-05       Impact factor: 3.478

7.  Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets.

Authors:  Ashley D Reynolds; David K Stone; R Lee Mosley; Howard E Gendelman
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 8.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

9.  Late stages of hematopoiesis and B cell lymphopoiesis are regulated by α-synuclein, a key player in Parkinson's disease.

Authors:  Wenbin Xiao; Afshin Shameli; Clifford V Harding; Howard J Meyerson; Robert W Maitta
Journal:  Immunobiology       Date:  2014-07-22       Impact factor: 3.144

Review 10.  Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.

Authors:  Katherine E Olson; Howard E Gendelman
Journal:  Curr Opin Pharmacol       Date:  2015-11-11       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.